ArticleJournal of the American Chemical Society2019
Direct Intermolecular Anti-Markovnikov Hydroazidation of Unactivated Olefins.
Article in Journal of the American Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 56 citations in OpenAlex.
- Total synthesis of pyridine-containing natural product Lycodine as well as its dimers and derivatives.Molecular diversity · 2026Review
- Pillar[5]arene-catalyzed anti-Markovnikov halogenations through cationic intermediates stabilization in confined spaces.Nature communications · 2026Article
- Evolution of manganese low-energy photoredox catalysis from high-energy visible light photocatalysis.Nature communications · 2026Article
- Regioretention Probes Distinguish Ring Scission Mechanisms in Nitrogen Insertion Reactions.Tetrahedron letters · 2025Article
- Photocatalytic anti-Markovnikov hydro- and haloazidation of alkenes.Nature communications · 2025Article
- Indirect Anti-Markovnikov Hydrofunctionalization of Terminal Alkenes via an Alkenyl Thianthrenium Intermediate.Angewandte Chemie (International ed. in English) · 2025Article
- Comparative analysis of complanadine A total syntheses.Beilstein journal of organic chemistry · 2025Review
- Recent Progress in Synthetic Applications of Hypervalent Iodine(III) Reagents.Chemical reviews · 2024Review
- Neurotrophic Natural Products.Progress in the chemistry of organic natural products · 2024Article
- Concise Total Synthesis of Complanadine A Enabled by Pyrrole-to-Pyridine Molecular Editing.Synthesis · 2024Article
- Iron-Mediated Photochemical Anti-Markovnikov Hydroazidation of Unactivated Olefins.Journal of the American Chemical Society · 2023Article
- Regio- and enantioselective remote dioxygenation of internal alkenes.Nature chemistry · 2023Article
- One-Carbon Insertion and Polarity Inversion Enabled a Pyrrole Strategy to the Total Syntheses of Pyridine-ContainingJournal of the American Chemical Society · 2021Article
- Ligand-promoted cobalt-catalyzed radical hydroamination of alkenes.Nature communications · 2020Article
- Anti-Markovnikov Hydroazidation of Activated Olefins via Organic Photoredox Catalysis.Synlett : accounts and rapid communications in synthetic organic chemistry · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
We herein report a direct intermolecular anti-Markovnikov hydroazidation method for unactivated olefins, which is promoted by a catalytic amount of bench-stable benziodoxole at ambient temperature. This method facilitates previously difficult, direct addition of hydrazoic acid across a wide variety of unactivated olefins in both complex molecules and unfunctionalized commodity chemicals. It conveniently fills a synthetic chemistry gap of existing olefin hydroazidation procedures, and thereby provides a valuable tool for azido-group labeling in organic synthesis and chemical biology studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.